Clinical trials
Obesity trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
344 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 11 |
| 2018 | 10 |
| 2019 | 23 |
| 2020 | 19 |
| 2021 | 22 |
| 2022 | 54 |
| 2023 | 38 |
| 2024 | 38 |
| 2025 | 52 |
| 2026 | 54 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 228 |
| Recruiting | 37 |
| Unknown status | 28 |
| Not yet recruiting | 27 |
| Active, not recruiting | 16 |
| Terminated | 3 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 16 |
| Istanbul University | 10 |
| Marmara University | 9 |
| Medipol University | 8 |
| Ondokuz Mayıs University | 8 |
| Pamukkale University | 8 |
| Hacettepe University | 7 |
| Ataturk University | 6 |
| Ege University | 6 |
| Fatih Sultan Mehmet Training and Research Hospital | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 344 |
| Overweight | 86 |
| Weight Loss | 20 |
| Obesity, Morbid | 19 |
| Diabetes Mellitus, Type 2 | 14 |
| Diabetes Mellitus | 11 |
| Insulin Resistance | 11 |
| Pediatric Obesity | 11 |
| Polycystic Ovary Syndrome | 11 |
| Inflammation | 6 |
Trials
Showing 26 to 50 of 344. Each trial links to its page on Pharma Observatory.
244 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.